Cannabics Pharmaceuticals Receives Positive Results In Drug Sensitivity Tests On CTCs

Cannabics Pharmaceuticals Inc announced it received positive results from screening necrosis of circulating tumor cells, from cancer patients, treated with the cannabinoids CBD and CBDA.

eTheRNA advances in-vivo mRNA cancer immunotherapy into first oncology clinical studies

eTheRNA immunotherapies, a clinical-stage company developing mRNA based cancer immunotherapies from its unique TriMix platform, announces the start of the first Phase Ib oncology...

Imprimis Pharmaceuticals Sells Pennsylvania Facility and Sinus Assets

Imprimis Pharmaceuticals, Inc , announced it has entered into an agreement to sell its Folcroft, Pennsylvania facility and sinus related assets for 450,000 dollars

Interview

In an Interview with
Dr. Mike Schaefers of West Pharmaceutical Services, Inc

This Interview was taken by World Pharma Today at the National Convention and Exhibition Center in Shanghai, China

Idifarma approved for EU-GMP commercial capsule manufacturing

A Spanish contract development and manufacturing organisation (CDMO) has expanded its GMP manufacturing offering with the installation of new automatic capsule filling capabilities at its EU-GMP approved plant in Pamplona, Spain. .

Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group

Valeant Pharma announced that its affiliate has completed the sale of all of the outstanding equity interests in its former subsidiary Dendreon Pharmaceuticals LLC to the Sanpower Group...

Eiger BioPharma announces sale of non-strategic assets to theragene pharmaceuticals

Eiger BioPharmaceuticals Inc , announced an agreement to sell to Theragene Pharmaceuticals, Inc., a private biotechnology company, a non-strategic asset, Mydicar.

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com